Bronstein, Gewirtz & Grossman LLC Urges Megan Holdings Limited Investors to Act: Class Action Filed Alleging Investor Harm

LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026